IRCT20220211053992N37招募中Unknown
In vivo fasted-state bioequivalence study of ?Azithromycin 500 mg tablet manufactured by Exir Pharmaceutical Co. compared to innovator product
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney diseases)
- •Age between 18 to 59 years
排除标准
- •History of cardiovascular, liver, and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
尚未招募
不适用
Investigating the in vivo bioequivalence of Azithromycin 500 mg capsuleIRCT20210519051345N12Tabriz University of Medical Sciences24
招募中
不适用
In vivo bioequivalence study of Azithromycin 250 mg tabletIRCT20210519051345N9Tabriz University of Medical Sciences24
招募中
Unknown
Investigating the in vivo bioequivalence of Escitalopram 20 mg tabletIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N55Tabriz University of Medical Sciences24
招募中
不适用
In vivo bioequivalence study of Imatinib 100 mg capsuleIRCT20210519051345N6Tabriz University of Medical Sciences24
尚未招募
Unknown
In vivo Bioequivalence study of Famotidine tabletIRCT20220211053992N35Tabriz University of Medical Sciences24